Xeljanz XR 11 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FXVN5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,970
Award facts
- Contract value 100% obligated
- $13,970.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $13,970.42 on January 27, 2026, for the supply of XELJANZ XR 11 MG tablets (30-count units). This firm fixed-price, non-set-aside award was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to support federal healthcare procurement needs. The contract has an ultimate completion date of January 28, 2026, and performance will be executed at the awardee's Conshohocken, Pennsylvania location.
This delivery order is issued under AmerisourceBergen's parent company, Cencora, Inc. (doing business as AmerisourceBergen), which holds a substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031. That prime contract vehicle serves as the comprehensive pharmaceutical support platform enabling the delivery of a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs and other federal medical institutions globally. AmerisourceBergen's federal contract portfolio demonstrates consistent capability to deliver pharmaceutical products across multiple therapeutic domains in support of defense and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FXVN5?
SPE2DR26FXVN5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26FXVN5 worth?
The government has obligated $13,970 on SPE2DR26FXVN5.
Is contract SPE2DR26FXVN5 an order under another contract?
Yes. SPE2DR26FXVN5 is a delivery order under SPE2DR25D3004, an indefinite delivery contract.
Was contract SPE2DR26FXVN5 competed?
The extent of competition for SPE2DR26FXVN5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award